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Abstract
Introduction—Eliminating and/or inhibiting bacterial growth within the root canal system have 
been shown to play a key role in the regenerative outcome. The aim of this study was to synthesize 
and determine in vitro both the antimicrobial effectiveness and cytocompatibility of bi-mix 
antibiotic-containing polydioxanone (PDS)-based polymer scaffolds.
Methods—Antibiotic-containing (metronidazole, MET and ciprofloxacin, CIP) polymer 
solutions (distinct antibiotic weight ratios) were spun into fibers as a potential mimic to the double 
antibiotic paste (DAP, a MET/CIP mixture). Fiber morphology, chemical characteristics, and 
tensile strength were evaluated by scanning electron microscopy (SEM), Fourier transform 
infrared spectroscopy (FTIR), and tensile testing, respectively. Antimicrobial efficacy was tested 
over time (aliquot collection) against Enterococcus faecalis (Ef), Porphyromonas gingivalis (Pg), 
and Fusobacterium nucleatum (Fn). Similarly, cytotoxicity was evaluated in human dental pulp 
stem cells (hDPSCs). Data were statistically analyzed (p<0.05).
Results—SEM and FTIR confirmed that electrospinning was able to produce antibiotic-
containing fibers with diameter mostly in the nanoscale. Tensile strength of 1:1MET/CIP scaffolds 
was significantly (p<0.05) higher than pure PDS (control). Meanwhile, all other groups presented 
similar strength as the control. Aliquots obtained from antibiotic-containing scaffolds inhibited 
growth of Ef, Pg and Fn, except pure MET that did not show an inhibitory action towards Pg or 
Fn. Antibiotic-containing aliquots promoted slight hDPSCs viability reduction, but none of them 
were considered to be cytotoxic.
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Conclusion—Our data suggest that the incorporation of multiple antibiotics within a 
nanofibrous scaffold holds great potential towards the development of a drug delivery system for 
regenerative endodontics.
Keywords
Electrospinning; nanofibers; scaffold; disinfection; regeneration; root canal; antibiotic; bacteria; 
stem cells; pulp
Traumatic injuries in addition to dental caries are the most common causes of pulp necrosis, 
and ultimately, if left untreated, tooth loss (1, 2). It is known that the incidence of pulpal 
necrosis in permanent teeth with incomplete apex formation (i.e., immature) poses a serious 
risk to fracture and thus to long-term survival, due to the thin and frequently short root (3-7). 
Over the past decade, root development and revascularization have been reported in the 
necrotic immature teeth. Concisely, this two-step regenerative procedure involves, initially, 
the disinfection of the root canal system with irrigation solutions and minimal 
instrumentation followed by placement of a medication containing a mixture of antibiotics 
(7-11). Generally, after 4 weeks, the medication is removed and the periapical tissue is 
lacerated to induce bleeding and subsequent blood clot formation (7-11). It has been 
assumed that the blood clot carries a variety of growth factors and acts as a natural, fibrin-
based scaffold for the attachment, proliferation and differentiation of stem cells from the 
apical papillae (7, 10). Worth mentioning, eliminating and/or inhibiting bacterial growth 
have been shown to play a key role in the regenerative outcome (7, 9, 10).
Knowing the limitations associated with currently advocated regenerative endodontics 
procedures, i.e., tooth discoloration caused by minocycline (7, 9), and cell toxicity (10, 12) 
associated with the use of high levels of antibiotics (∼ 1g/mL), our group developed, for the 
first time, antibiotic-containing nanofibers that can be potentially used as a drug delivery 
system and as a scaffold for regenerative endodontics (13). Here, distinct combinations 
(MET and CIP weight ratios) of antibiotic-containing polymer solutions were spun into 
fibers as a potential mimic to the clinically available DAP. We hypothesized that the 
combination MET/CIP would show (1) no antimicrobial differences against the selected 
bacteria, and (2) no toxicity on hDPSCs, when compared to the single antibiotic-containing 
scaffolds.
Materials and Methods
Synthesis and Characterization of the Antibiotic-Containing Polymer Scaffolds
Bi-mix scaffolds were synthesized via electrospinning (Figure 1A), based on the formulation 
of single antibiotic-containing (i.e., MET and CIP) scaffolds, the details of which have been 
described elsewhere (13). Scanning electron microscopy (SEM, JSM-5310LV, JEOL, 
Tokyo, Japan) was performed to assess fiber morphology and scaffold structure. Fiber 
diameter was determined from the SEM images using ImageJ (1.44i, National Institutes of 
Health, USA). The tensile strength of the scaffolds (15 × 3 mm2, n=6/group), was evaluated 
by uni-axial tensile testing (expert 5601, ADMET, Norwood, MA) (13, 14). To confirm 
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antibiotic incorporation, Fourier transform infrared spectroscopy (FTIR, Jasco 4100, Easton, 
MD) using attenuated total reflection (ATR) was conducted (13).
Antimicrobial Testing
Antibiotic incorporation/release was further investigated by means of an agar diffusion 
testing against Ef, Pg, and Fn. Phosphate buffered saline (PBS, pH 7.4; GIBCO BRL, Grand 
Island, New York, USA) aliquots containing antibiotics released from the scaffolds were 
prepared. Briefly, rectangular-shaped scaffolds (n=3/group, 4.0±0.2 mg) were cut and 
disinfected by UV light (15 min each side) and rinsed twice with sterile PBS. Disinfected 
samples were placed into 24-well plates containing sterile PBS (5 mL). 500 μL aliquots were 
withdrawn at days 1, 3, 7, and 14. An equal amount of fresh PBS was added to the wells to 
replace the volume removed. Aliquots were stored at -20°C until used (15).
Ef (ATCC 29212) was cultured aerobically in tryptic soy broth (Difco Laboratories, Detroit, 
MI) for 24 h in 5% CO2 at 37°C. Meanwhile, Pg (ATCC 33277) and Fn (ATCC 25586) 
were cultured for 24 h anaerobically in Brain heart infusion (BHI) containing 5 g/L yeast 
extract (Difco) with 5% v/v Vitamin K/hemin solution (Thermo Scientific, Pittsburgh, PA) 
in an anaerobic GasPak jar (13). Then, 100 μL of each bacterial suspension was swabbed 
onto blood agar plates (BAP, Fisher Scientific, Pittsburgh, PA) to create a lawn of bacteria. 
Each agar plate was divided into four zones and 10 μL aliquots from days 1, 3, 7, and 14 
were pipetted into the center of each zone. Afterwards, the BAPs were incubated according 
to the bacteria strain. Chlorhexidine (0.12%) and sterile PBS served as positive and negative 
controls, respectively. After 2 days of incubation, either in aerobic or anaerobic conditions 
based on the bacteria tested, the diameters (in mm) of the clear zones of growth inhibition 
were determined (13).
Cytocompatibility
Low glucose Dulbecco's Modified Eagle's Medium (DMEM, Gibco, Grand Island, NY) 
supplemented with 10% FBS (Hyclone, Logan, UT) was used to obtain the aliquots. 
Similarly to the antimicrobial assay, three rectangular-shaped scaffolds per group (4.0±0.2 
mg) were incubated in DMEM up to 14 days (15). hDPSCs (AllCells LLC., Alameda, CA) 
obtained from permanent third molars were cultured in low glucose DMEM containing 10% 
FBS and 1% penicillin–streptomycin (Sigma) in a humidified incubator at 37°C, with 5% 
CO2 (13). hDPSCs at passages 3-6 were used. Aliquots were filtered through a membrane 
(Millipore®). The positive control was a 0.3 vol % phenol solution (13). Tests for each 
aliquot and time point were done in triplicate. hDPSCs were seeded at a density of 3×103/
well (100 μL cell suspension) and allowed to adhere in 96-well tissue culture microtiter 
plates (13). After 4 h of incubation the media was removed and replaced by the collected 
aliquots (100 μL) that were adjusted to 10% FBS and 1% penicillin–streptomycin and the 
positive control. Control (blank) wells in quadruplicate were prepared using medium 
without cells, and medium with cells but without the aliquot (100% survival) (13). The 
microplate was then incubated in a 5% CO2 humidified atmosphere. After 3 days, 20 μL of 
CellTiter 96 AQueous One Solution Reagent (Promega, Madison, WI) was added to the test 
wells and allowed to react for 2 h. Incorporated dye was measured by reading the 
absorbance at 490 nm in a microplate reader against blank wells (13, 16).
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Statistical Analysis
The fiber diameter and tensile strength of the scaffolds were analyzed using oneway 
ANOVA. Inhibition zone and cytocompatibility of each group was compared using an 
ANOVA that included a random effect to account for correlations within a specimen over 
time. Tukey's post-hoc test was used to count for differences among groups. The level of 
significance was set at 5%.
Results
Scaffolds Characterization
Figure 1 (B-E) shows representative SEM images of the bi-mix antibiotic-containing 
scaffolds and the pure PDS. A micro/nanofibrous network with interconnected pores was 
observed for all groups. The fiber diameter of antibiotic-containing scaffolds ranged 
between 541.43±246.73 nm and 770.09±295.71 nm, and was considerably smaller (p<0.05) 
than the pure PDS (1179.68±449.94 nm). The morphologic aspects of CIP and MET only 
scaffolds (data are not shown) are in agreement with that presented in our previous study 
(13). Apart from the polymer related peaks, FTIR analysis (data are not shown) confirmed 
the presence of the antibiotics in the scaffolds.
Mechanical Strength
Tensile strength measurements of the scaffolds (in MPa) were in an ascending order as 
follows: 3.45±0.51 (G4-1:3MET/CIP), 3.53±0.52 (G5-3:1MET/CIP), 4.32±0.53 (Pure PDS), 
4.38±0.46 (G1-MET only), 5.13±0.67 (G2-CIP only), and 6.05±0.63 (G3-1:1MET/CIP). 
The tensile strength of G3 (1:1MET/CIP) was significantly (p<0.05) higher than the control 
(PDS). Meanwhile, all the other groups (G1, G2, G4, and G5) presented similar strengths as 
the control.
Antimicrobial testing
Antibiotic-containing scaffolds inhibited growth of Ef, Pg and Fn, except G1 (MET only) 
that did not show an inhibitory action towards Pg or Fn (Figure 2). Scaffolds containing 
higher CIP amounts (i.e., G2-CIP only, G3-1:1MET/CIP, and G4-1:3MET/CIP) had larger 
or at least comparable inhibition zones than those of G5 (3:1MET/CIP). The inhibition 
zones on Ef were smaller than those of Pg and Fn, indicating higher antibacterial efficacy 
against Pg and Fn.
Cytocompatibility
Figure 3 shows hDPSCs viability as a comparison within the same day antibiotic-containing 
aliquots. A significant reduction in cell viability was seen at day 1 for G3 (1:1MET/CIP) 
when compared with pure PDS (control). Furthermore, cell viability of G3 at day 1 was also 
significantly lower (p<0.05) than that of G4 and G5. At day 14, cell viability of G1 (MET 
only) was significantly higher than G2 (CIP only). No other significant differences were 
found.
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Discussion
One of the major goals of endodontic therapy is to eliminate microbial infection, typically a 
multi-species infection consisting of aerobic and anaerobic bacteria (17). The majority of 
bacteria inside the root canal are obligate anaerobes, thus MET is the first choice of 
antibiotic (17). CIP, a DNA gyrase inhibitor, is a very potent antibiotic against gram-
negative pathogens but the activity is very limited against gram-positives. Consequently, it 
is often combined with MET in the treatment of mixed infections (18).
To the best of our knowledge, this is the first study that combined MET and CIP in a 
biodegradable polymer to obtain bi-mix (MET/CIP) antibiotic-containing nanofibers for 
application as drug delivery systems in regenerative endodontics. This study can be seen as 
an extension of our prior research (13) in that the use of a biocompatible bi-mix antibiotic-
containing scaffold should lead to enhanced antimicrobial activity without the side-effects of 
staining and cell toxicity. Here, mechanical properties of these scaffolds were studied. The 
synthesized scaffolds demonstrated adequate mechanical properties, capable of sustaining 
handling and eventual placement inside root canals. Morphologically, the mean fiber 
diameter was in the nanoscale range and was even smaller than the pure PDS (Figure 1). 
This holds potential benefit because the smaller diameter creates more surface area and 
theoretically more drug release over an extended period of time (19-22).
Our study further demonstrated the antibacterial efficacy of the antibiotics released from the 
bi-mix scaffolds against Ef, Pg and Fn. These bacteria were chosen as the test species due to 
their possible microbial role in root canal infection, particularly Ef, a common 
microorganism associated with refractory infection (23, 24). Taken together, the results from 
FTIR and the agar diffusion testing confirmed that antibiotics were not only incorporated 
into the scaffolds but the drugs were also released since inhibition of bacterial growth was 
seen. Generally, the higher the CIP concentration (G2-CIP only, G3-1:1MET/CIP, and 
G4-1:3MET/CIP), the greater the zones of inhibition. Unexpectedly, MET only (G1) did not 
inhibit growth of Pg and Fn, thus, those results led us to reject the first null hypothesis 
(Figure 2). At present, and without quantitatively confirming, at each time point, the amount 
of drug released, for example by high performance liquid chromatography (HPLC), one 
plausible explanation could be that the amounts collected, based on the protocol used, might 
not have reached the minimal inhibitory concentrations (MIC) against Ef (>256 μg/mL) (25), 
Pg (0.031-1.5 μg/mL) (15, 26, 27), and Fn (0.242 μg/mL) (28). It has been reported that as 
low as 0.001 mg/mL of double antibiotic paste (DAP) can inhibit (MIC) the growth of Ef 
and Pg (29). Moreover, inhibitory effects against Ef exhibited no significant difference 
between 5 wt.%CIP and 25 wt.%CIP (same as used in this study) containing scaffolds (13). 
This might suggest that the lower concentration of CIP would have shown positive results. 
On the other hand, MET containing scaffolds significantly inhibited growth of Pg, 
disagreeing with the results observed in this study, possibly due to the different antibacterial 
methods used, i.e., direct contact of scaffolds with the bacteria (13), versus the released 
media used herein. Even though the combination of antibiotics inhibited growth of Ef, Pg 
and Fn, the inhibition might have resulted mostly from CIP, since pure MET did not inhibit 
the growth of sensitive bacteria (Pg and Fn).
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Apart from the necessity of evaluating the kinetics of drug release, increasing the MET 
concentration could also be proposed in a future investigation. The combination of MET and 
CIP is still needed because endodontic infections generally involve multiple species, and 
only three bacteria were investigated in this study. Nonetheless, it is important to highlight 
that the present study is a follow-up from our previous work, in which we synthesized 
polymer-based scaffolds containing antimicrobial drugs that are part of the double antibiotic 
paste (i.e., metronidazole and ciprofloxacin) at different concentrations to address their 
individual antimicrobial potential against endodontic-related pathogens (13). In that study, 
two distinct antimicrobial assays were performed to evaluate both the direct antimicrobial 
effect by direct contact between bacteria/scaffold, as well as on a biofilm model, in which 
bacteria were inoculated on the scaffolds (13). Our previous and present studies have 
demonstrated significant antimicrobial activity both by direct contact and by the release of 
the drugs on endodontic-related pathogens, respectively. Taken together, these findings have 
provided proof-of-concept for us to proceed with more clinically relevant investigations, 
such as multispecies biofilm infected dentin models.
Overall, our data revealed that the synthesized bi-mix antibiotic-containing scaffolds had 
slight toxicity (60%-90% cell viability) or non-cytotoxicity (>90% cell viability), therefore 
supporting the acceptance of our second hypothesis, where none of the groups evaluated 
revealed cell death below 50% (Figure 3), according to previously established criteria (30). 
This may be due to the fact that we incorporated only a maximum of 25 wt.% (i.e., 150 mg 
of drugs combined or individually) of drugs into the PDS solution and the concentration of 
antibiotic released may be even lower than the initial concentration, as shown previously 
(13).
Recent data provided in the literature strongly highlight the need of using low antibiotic 
concentrations prior to regenerative endodontics procedures. Together, this study 
demonstrated that MET- and CIP-containing scaffolds demonstrated antibacterial efficacy 
against Ef, Pg and Fn with slight or no toxicity on hDPSCs. Therefore, within the limitations 
of this study, it can be concluded that using bi-mix (MET/CIP) antibiotic-containing 
scaffolds has great potential as an alternative medicament to DAP due to the proven 
antibacterial efficacy and reduced impact on cell viability.
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Figure 1. 
(A) Polydioxanone suture filaments (PDS II®, Ethicon, Somerville, NJ) were first undyed 
using dichloromethane (Sigma-Aldrich, St. Louis, MO) and then dissolved in 1,1,1,3,3,3-
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hexafluoro-2-propanol (HFP, Sigma-Aldrich) at 10 wt.% under stirring conditions. MET 
(Sigma-Aldrich) and CIP (Sigma-Aldrich) containing solutions were prepared by adding 
MET (G1) and CIP (G2) into the PDS solution at a 25 wt.% relative to the total PDS weight 
(i.e., 150 mg of the antibiotic) and mixed together under vigorous stirring. Different ratios 
(by weight) of the two antibiotics were added to PDS solutions and mixed under vigorous 
stirring to obtain the following antibiotic-containing solutions: G3-1:1MET/CIP (75 mg of 
each antibiotic), G4-1:3MET/CIP (37.5 mg/112.5 mg), and G5-3:1MET/CIP (112.5 mg/37.5 
mg). The antibiotic-containing and pure PDS (control) solutions were electrospun under 
optimized parameters. The electrospun scaffolds (hereafter referred to as mats) were 
desiccated under vacuum at ambient conditions for 48 h (13). (B-E) Representative SEM 
micrographs of antibiotic-containing mats at 3,500×: (B) G6-Pure PDS; (C) G3-1:1MET/
CIP; (D) G4-1:3MET/CIP, and (E) G5-3:1MET/CIP.
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Figure 2. 
Results from agar diffusion assays are represented as mean inhibition zone (in mm) against 
the different bacteria tested: (A) E. faecalis; (B) P. gingivalis; and (C) F. nucleatum. Same 
letters indicate insignificant difference compared to the results of the same day of aliquots. 
Aliquots from PBS (negative control), Pure PDS (control), and G1 (MET only) showed no 
inhibition zone on the three tested bacteria and are not shown.
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Figure 3. 
Cytotoxicity assay measured viability (%) of human dental pulp stem cells (hDPSCs) in 
response to aliquots at day 1, 3, 7 and 14 from electrospun mats. Statistical analyses were 
compared with the same day results. *At day 1, cell viability of G3-1:1MET/CIP was 
significantly lower than that of Pure PDS, G4-1:3MET/CIP, and G5-3:1MET/CIP.  At day 
14, cell viability of G1-MET only was significantly higher than that of G2-CIP only. No 
other significant differences were found among the other groups.
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